SIRT2 (Sirtuin 2) has been shown to mediate dopaminergic neuronal loss in PD, and SIRT2 knockdown effectively ameliorates abnormal behavioral phenotypes in a transgenic mouse model of PD [119]. Here, SIRT2 is linked to Parkinson disease.